Background—Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a primary heart muscle disorder resulting from desmosomal protein mutations. ARVC is characterized pathologically by fibrofatty infiltration and clinically by arrhythmias and sudden cardiac…
Cardiovascular medicine has recently implemented multiple pre-clinical and clinical trials intended to identify a feasible and safe approach for cell-based heart repair. In the myocardium, several recent studies demonstrate the…
Aims Adipose-derived regenerative cells (ADRCs) can be isolated from liposuction aspirates and prepared as fresh cells for immediate administration in cell therapy. We performed the first randomized, placebo-controlled, double-blind trial…
Aims Few studies have assessed the effects of cell therapy in non-ischemic cardiomyopathies which, however, contribute to a large number of cardiac failures. Assuming that such conditions are best suited…